127 related articles for article (PubMed ID: 24091316)
1. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis.
Kim HR; Kim HK; Oh DJ
Clin Nephrol; 2013 Nov; 80(5):322-7. PubMed ID: 24091316
[TBL] [Abstract][Full Text] [Related]
2. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients.
Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ
Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088
[TBL] [Abstract][Full Text] [Related]
3. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients.
Talib A; Nakagawa N; Saito E; Matsuki M; Kobayashi M; Akasaka K; Hirayama T; Ishida H; Sato N; Hasebe N
Hypertens Res; 2012 Apr; 35(4):426-33. PubMed ID: 22129515
[TBL] [Abstract][Full Text] [Related]
4. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients.
Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC
Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842
[TBL] [Abstract][Full Text] [Related]
5. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
[TBL] [Abstract][Full Text] [Related]
6. Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
Lyu B; Banerjee T; Scialla JJ; Shafi T; Yevzlin AS; Powe NR; Parekh RS; Astor BC
Am J Nephrol; 2018; 48(5):330-338. PubMed ID: 30380526
[TBL] [Abstract][Full Text] [Related]
7. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.
Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D
BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931
[TBL] [Abstract][Full Text] [Related]
8. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes.
Koluman BU; Mutluay R; Derici UB; Arinsoy T; Senlik Z; Bahar B; Sancak B; Oktan SO; Sindel S
Clin Nephrol; 2013 Jul; 80(1):9-16. PubMed ID: 23458176
[TBL] [Abstract][Full Text] [Related]
9. Is fetuin-A a biomarker of dialysis access dysfunction?
Roca-Tey R; Ramírez de Arellano M; González-Oliva JC; Roda A; Samon R; Ibrik O; Ugalde-Altamirano J; Viladoms J; Calls J
J Vasc Access; 2023 May; 24(3):458-464. PubMed ID: 34325543
[TBL] [Abstract][Full Text] [Related]
10. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study.
Wu WT; Lee RP; Wang CH; Fang TC; Lin NT; Chen IH; Hsu BG
J Womens Health (Larchmt); 2010 Apr; 19(4):785-90. PubMed ID: 20210559
[TBL] [Abstract][Full Text] [Related]
11. Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients.
Dukkipati R; Molnar MZ; Park J; Jing J; Kovesdy CP; Kajani R; Kalantar-Zadeh K
Semin Dial; 2014; 27(4):415-23. PubMed ID: 24118625
[TBL] [Abstract][Full Text] [Related]
12. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
[TBL] [Abstract][Full Text] [Related]
14. Relationship of late arteriovenous fistula stenosis with soluble E-selectin and soluble EPCR in chronic hemodialysis patients with arteriovenous fistula.
Bilgic MA; Yilmaz H; Bozkurt A; Celik HT; Bilgic IC; Gurel OM; Kirbas I; Bavbek N; Akcay A
Clin Exp Nephrol; 2015 Feb; 19(1):133-9. PubMed ID: 24627030
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
16. [Study of vascular access (VA) by color Doppler ultrasonography (CDU). Comparison between delta-H and CDU methods in measuring VA blood flow rate].
Roca-Tey R; Rivas A; Samon R; Ibrik O; Viladoms J
Nefrologia; 2005; 25(6):678-83. PubMed ID: 16514909
[TBL] [Abstract][Full Text] [Related]
17. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients.
Movilli E; Brunori G; Camerini C; Vizzardi V; Gaggia P; Cassamali S; Scolari F; Parrinello G; Cancarini GC
Blood Purif; 2006; 24(4):387-93. PubMed ID: 16755161
[TBL] [Abstract][Full Text] [Related]
18. Serum fetuin-A levels, QT dispersion and P dispersion in dialysis patients.
Taskapan MC; Taskapan H; Comert M; Temel I; Yagmur J; Ulutas O
Ren Fail; 2013; 35(4):477-82. PubMed ID: 23438291
[TBL] [Abstract][Full Text] [Related]
19. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.
Liu BC; Li L; Gao M; Wang YL; Yu JR
Chin Med J (Engl); 2008 Nov; 121(21):2157-61. PubMed ID: 19080177
[TBL] [Abstract][Full Text] [Related]
20. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
Grzegorzewska AE; Młot M
Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
